Olaregen Therapeutix Inc. — Form D
Olaregen Therapeutix Inc. of NEW YORK, NY, a company, filed a Form D exempt-offering notice with the SEC on 2018-09-06. The offering totals $1.2M, of which $450K was reported sold. Industry: Biotechnology.
Offering
- Filed: 2018-09-06
- Form: D
- Accession: 0001752061-18-000001
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $1.2M
- Amount sold: $450K
- Remaining: $719K
- Investors: 1
- Date of first sale: 2018-08-29
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-320753
Issuer
- Name: Olaregen Therapeutix Inc.
- CIK: 0001752061
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2017
- Address: 1001 AVENUE OF THE AMERICAS, NEW YORK, NY, 10018
- Phone: 631-495-3467
Officers, directors & promoters (4)
| Name | Role | Location |
|---|
| Wesley Ramjeet | Director | New York, NY |
| Anthony Dolisi | Executive Officer | New York, NY |
| Scott Emmens | Executive Officer | New York, NY |
| Wesley Ramjeet | Executive Officer | New York, NY |
More